Gene Matrix Announces Global Expansion and Upcoming Series A Funding Round for AI-Powered Genomics Platform
Global expansion drives $500M valuation for Gene Matrix. Prevents 30K+ adverse drug reactions yearly. US subscription launched. Series A opens soon. Gene Matrix Inc., a biotechnology company specializing in AI-powered genomic testing, announced its expansion into multiple international markets and plans to launch a Series A funding round. The company’s......